Variant report

Variant	esv3416587
Chromosome Location	chr3:146191303-146222138
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:456)
CpG islands
(count:366)
Chromatin interactive
region (count:21)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:456 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:146221507-146221707	HepG2	liver:	n/a	n/a
2	ARID3A	chr3:146214109-146214902	K562	blood:	n/a	n/a
3	ATF1	chr3:146214386-146214920	K562	blood:	n/a	n/a
4	ATF2	chr3:146221234-146221948	GM12878	blood:	n/a	n/a
5	ATF2	chr3:146221449-146221919	GM12878	blood:	n/a	n/a
6	BACH1	chr3:146221416-146221743	H1-hESC	embryonic stem cell:	n/a	n/a
7	BATF	chr3:146221528-146221840	GM12878	blood:	n/a	chr3:146221767-146221775 chr3:146221712-146221722
8	BATF	chr3:146221274-146221942	GM12878	blood:	n/a	chr3:146221767-146221775 chr3:146221712-146221722
9	BATF	chr3:146219489-146219901	GM12878	blood:	n/a	n/a
10	BATF	chr3:146219538-146219823	GM12878	blood:	n/a	n/a
11	BCL11A	chr3:146221585-146221875	GM12878	blood:	n/a	chr3:146221711-146221720
12	BCL11A	chr3:146221581-146221886	GM12878	blood:	n/a	chr3:146221711-146221720
13	BCL3	chr3:146221292-146221921	A549	lung:	n/a	chr3:146221711-146221720
14	BCLAF1	chr3:146221476-146221935	GM12878	blood:	n/a	chr3:146221711-146221720
15	BHLHE40	chr3:146221533-146221936	GM12878	blood:	n/a	n/a
16	BHLHE40	chr3:146214373-146214958	K562	blood:	n/a	n/a
17	CBX3	chr3:146214328-146214948	K562	blood:	n/a	n/a
18	CBX3	chr3:146221270-146222072	HCT-116	colon:	n/a	n/a
19	CBX3	chr3:146221110-146222066	HCT-116	colon:	n/a	n/a
20	CCNT2	chr3:146214376-146215084	K562	blood:	n/a	chr3:146214637-146214657 chr3:146214578-146214587
21	CEBPB	chr3:146214531-146214787	K562	blood:	n/a	chr3:146214736-146214747
22	CEBPB	chr3:146221584-146221913	GM12878	blood:	n/a	n/a
23	CEBPB	chr3:146211010-146211953	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr3:146220810-146222002	HCT-116	colon:	n/a	n/a
25	CEBPB	chr3:146214424-146214955	K562	blood:	n/a	chr3:146214736-146214747
26	CEBPB	chr3:146221380-146221980	GM12878	blood:	n/a	n/a
27	CEBPB	chr3:146214405-146214914	K562	blood:	n/a	chr3:146214736-146214747
28	CEBPB	chr3:146211090-146211909	IMR90	lung:	n/a	n/a
29	CEBPB	chr3:146192885-146193149	A549	lung:	n/a	chr3:146192976-146192987
30	CEBPB	chr3:146209104-146209496	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr3:146192803-146193096	K562	blood:	n/a	chr3:146192976-146192987
32	CEBPB	chr3:146221080-146221923	HCT-116	colon:	n/a	n/a
33	CEBPB	chr3:146192795-146193153	HepG2	liver:	n/a	chr3:146192976-146192987
34	CEBPB	chr3:146192870-146193199	MCF-7	breast:	n/a	chr3:146192976-146192987
35	CEBPB	chr3:146192798-146193158	K562	blood:	n/a	chr3:146192976-146192987
36	CEBPB	chr3:146192877-146193148	MCF-7	breast:	n/a	chr3:146192976-146192987
37	CEBPB	chr3:146216285-146216320	A549	lung:	n/a	n/a
38	CEBPB	chr3:146209133-146209432	IMR90	lung:	n/a	n/a
39	CEBPB	chr3:146192890-146193127	IMR90	lung:	n/a	chr3:146192976-146192987
40	CEBPB	chr3:146192896-146193088	Hela-S3	cervix:	n/a	chr3:146192976-146192987
41	CEBPB	chr3:146211395-146211831	A549	lung:	n/a	n/a
42	CEBPB	chr3:146221210-146221918	Hela-S3	cervix:	n/a	n/a
43	CEBPB	chr3:146192800-146193078	K562	blood:	n/a	chr3:146192976-146192987
44	CEBPB	chr3:146211460-146211842	K562	blood:	n/a	n/a
45	CEBPD	chr3:146214410-146214970	K562	blood:	n/a	n/a
46	CEBPD	chr3:146214350-146214964	K562	blood:	n/a	n/a
47	CHD2	chr3:146214424-146214727	K562	blood:	n/a	n/a
48	CHD2	chr3:146221328-146221846	Hela-S3	cervix:	n/a	n/a
49	CTCF	chr3:146221819-146221923	GM19240	blood:	n/a	n/a
50	CTCF	chr3:146221796-146221919	GM19238	blood:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:146213845-146213895	AoSMC	blood vessel:	n/a
2	chr3:146213718-146213768	ovcar-3	ovarian:	n/a
3	chr3:146213845-146213895	GM12878	blood:	n/a
4	chr3:146214926-146214976	HMEC	breast:	n/a
5	chr3:146213718-146213768	T-47D	breast:	n/a
6	chr3:146213718-146213768	HMEC	breast:	n/a
7	chr3:146214926-146214976	HNPCEpiC	eye:	n/a
8	chr3:146214926-146214976	SK-N-MC	brain:	n/a
9	chr3:146215095-146215145	SK-N-MC	brain:	n/a
10	chr3:146213718-146213768	ECC-1	luminal epithelium:	n/a
11	chr3:146213845-146213895	HRPEpiC	eye:	n/a
12	chr3:146213648-146213698	HEEpiC	esophagus:	n/a
13	chr3:146213648-146213698	PANC-1	pancreas:	n/a
14	chr3:146213648-146213698	SK-N-MC	brain:	n/a
15	chr3:146215095-146215145	GM12878	blood:	n/a
16	chr3:146191384-146191434	GM19239	blood:	n/a
17	chr3:146214926-146214976	PANC-1	pancreas:	n/a
18	chr3:146213648-146213698	SK-N-SH_RA	brain:	n/a
19	chr3:146213845-146213895	AG09319	gingival:	n/a
20	chr3:146215095-146215145	HRPEpiC	eye:	n/a
21	chr3:146191384-146191434	CMK	blood:	n/a
22	chr3:146215095-146215145	HRE	kidney:	n/a
23	chr3:146213718-146213768	A549	lung:	n/a
24	chr3:146213648-146213698	HCT-116	colon:	n/a
25	chr3:146215095-146215145	HCPEpiC	choroid plexus:	n/a
26	chr3:146215095-146215145	NH-A	brain:	n/a
27	chr3:146213718-146213768	AG10803	skin:	n/a
28	chr3:146214926-146214976	GM19239	blood:	n/a
29	chr3:146213718-146213768	HEK293	kidney:	embryo
30	chr3:146215095-146215145	NT2-D1	testis:	n/a
31	chr3:146215095-146215145	AG09309	skin:	n/a
32	chr3:146191384-146191434	NT2-D1	testis:	n/a
33	chr3:146213648-146213698	ECC-1	luminal epithelium:	n/a
34	chr3:146213648-146213698	NHDF-neo	bronchial:	n/a
35	chr3:146214926-146214976	NT2-D1	testis:	n/a
36	chr3:146213648-146213698	SK-N-SH	brain:	n/a
37	chr3:146214926-146214976	HAEpiC	amniotic membrane:	n/a
38	chr3:146213845-146213895	Caco-2	colon:	n/a
39	chr3:146213718-146213768	GM19239	blood:	n/a
40	chr3:146213845-146213895	PrEC	prostate:	n/a
41	chr3:146215095-146215145	A549	lung:	n/a
42	chr3:146213718-146213768	IMR90	lung:	fetal
43	chr3:146213845-146213895	BE2_C	brain:	n/a
44	chr3:146215095-146215145	HEK293	kidney:	embryo
45	chr3:146214926-146214976	Jurkat	blood:	n/a
46	chr3:146213648-146213698	HCM	heart:	n/a
47	chr3:146213648-146213698	BJ	skin:	n/a
48	chr3:146213648-146213698	HEK293	kidney:	embryo
49	chr3:146213718-146213768	HCF	heart:	n/a
50	chr3:146213648-146213698	MCF-7	breast:	n/a

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:146194067..146196930-chr3:146225397..146228308,2	K562	blood:
2	chr3:146219980..146222907-chr3:146245390..146248406,3	MCF-7	breast:
3	chr3:146215967..146218741-chr3:146227451..146229458,2	K562	blood:
4	chr3:146216037..146218626-chr3:146223449..146226621,3	K562	blood:
5	chr3:146216120..146218147-chr3:146219212..146221539,2	K562	blood:
6	chr3:146208157..146210968-chr3:146212553..146216425,3	K562	blood:
7	chr3:146214293..146216886-chr3:146219168..146220915,2	MCF-7	breast:
8	chr3:146187698..146189946-chr3:146195880..146197489,2	K562	blood:
9	chr3:146214293..146216886-chr3:146219168..146220915,2	MCF-7	breast:
10	chr3:146210468..146212270-chr3:146218804..146221427,2	MCF-7	breast:
11	chr3:146210468..146212270-chr3:146218804..146221427,2	MCF-7	breast:
12	chr3:146216120..146218147-chr3:146219212..146221539,2	K562	blood:
13	chr3:146220348..146223181-chr3:146248231..146251179,2	K562	blood:
14	chr3:146213959..146215487-chr3:146223971..146226967,2	K562	blood:
15	chr3:146220774..146222428-chr3:146226537..146229465,2	MCF-7	breast:
16	chr3:146219517..146222555-chr3:146227614..146231140,3	K562	blood:
17	chr3:146220962..146225419-chr3:146230623..146236617,7	MCF-7	breast:
18	chr3:146100063..146100757-chr3:146220788..146221766,2	MCF-7	breast:
19	chr3:146219569..146222344-chr3:146250325..146252358,2	K562	blood:
20	chr3:146139398..146141443-chr3:146220518..146223634,3	MCF-7	breast:
21	chr3:146220307..146222805-chr3:146260005..146263724,3	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PLSCR1-1	chr3:146212381-146212819	NONHSAT092558
2	lnc-PLSCR1-1	chr3:146213682-146213741	NONHSAT092558

No data

Variant related genes	Relation type
PLSCR2	TF binding region
PLSCR2	CpG island
ENSG00000163746	chromatin interactions
ENSG00000188313	chromatin interactions

Extended variants
information (count: 818 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:818 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs145863073	chr3:146191312-146191313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs138490631	chr3:146191339-146191340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs534338546	chr3:146191344-146191345	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs191676256	chr3:146191345-146191346	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs570930492	chr3:146191372-146191373	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs142907712	chr3:146191378-146191379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs183756497	chr3:146191445-146191446	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs146124957	chr3:146191456-146191457	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs138911489	chr3:146191499-146191500	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs541754599	chr3:146191501-146191502	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs149482654	chr3:146191537-146191538	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs189387394	chr3:146191548-146191549	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs562541979	chr3:146191554-146191555	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs34615772	chr3:146191628-146191629	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs563858371	chr3:146191635-146191636	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs534092	chr3:146191655-146191656	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs548689795	chr3:146191670-146191671	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs73152987	chr3:146191690-146191691	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs376001710	chr3:146191741-146191742	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs548587614	chr3:146191754-146191755	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs201330191	chr3:146191894-146191895	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs145246814	chr3:146191895-146191896	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs76257097	chr3:146191898-146191899	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs62272690	chr3:146191899-146191900	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs368415261	chr3:146191931-146191932	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs531301418	chr3:146191940-146191941	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs560598033	chr3:146191990-146191991	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs527901428	chr3:146192015-146192016	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs115935520	chr3:146192025-146192026	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs143966135	chr3:146192031-146192032	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs537771	chr3:146192053-146192054	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs538293738	chr3:146192082-146192083	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs182221056	chr3:146192108-146192109	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs148603328	chr3:146192109-146192110	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs142710887	chr3:146192111-146192112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs553758802	chr3:146192129-146192130	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs551484929	chr3:146192143-146192144	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs76440779	chr3:146192163-146192164	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs539270068	chr3:146192235-146192236	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs557488044	chr3:146192249-146192250	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs147419567	chr3:146192257-146192258	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs185564969	chr3:146192271-146192272	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs112203671	chr3:146192311-146192312	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs139779611	chr3:146192312-146192313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs561383858	chr3:146192316-146192317	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs35296568	chr3:146192324-146192325	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs540994434	chr3:146192354-146192355	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs77140637	chr3:146192362-146192363	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs527947133	chr3:146192365-146192366	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs145318441	chr3:146192369-146192370	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
Colorectal cancer	18645599	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Mental retardation	17847001	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Autism	18923514	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Autism	21956041	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:215 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:146188800-146195200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
2	chr3:146190200-146192400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr3:146190200-146192400	Enhancers	Muscle Satellite Cultured Cells	--
4	chr3:146190200-146193000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
5	chr3:146192400-146193000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
6	chr3:146193000-146193200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr3:146193000-146194200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
8	chr3:146194000-146194200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr3:146194000-146194400	Enhancers	Fetal Thymus	thymus
10	chr3:146194000-146195200	Enhancers	Fetal Stomach	stomach
11	chr3:146194200-146194400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr3:146194200-146194600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
13	chr3:146194400-146194600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr3:146194400-146194800	Enhancers	HSMMtube	muscle
15	chr3:146194600-146196600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr3:146208200-146209000	ZNF genes & repeats	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr3:146208800-146210000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr3:146209000-146209400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr3:146209000-146210000	Enhancers	Hela-S3	cervix
20	chr3:146209400-146209600	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr3:146209400-146210000	Enhancers	Muscle Satellite Cultured Cells	--
22	chr3:146209600-146209800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr3:146209600-146210000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr3:146209600-146210000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr3:146209600-146210000	Enhancers	NHDF-Ad	bronchial
26	chr3:146209800-146210800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr3:146210000-146211000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr3:146210000-146211000	Weak transcription	Muscle Satellite Cultured Cells	--
29	chr3:146210000-146211000	Weak transcription	Hela-S3	cervix
30	chr3:146210000-146211000	Weak transcription	NHDF-Ad	bronchial
31	chr3:146210000-146213000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr3:146210000-146213600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
33	chr3:146210800-146212000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr3:146211000-146211400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
35	chr3:146211000-146211800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr3:146211000-146211800	Enhancers	NHDF-Ad	bronchial
37	chr3:146211000-146212000	Enhancers	Muscle Satellite Cultured Cells	--
38	chr3:146211000-146212000	Enhancers	Hela-S3	cervix
39	chr3:146211200-146211400	Enhancers	iPS-15b Cell Line	embryonic stem cell
40	chr3:146211400-146221200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
41	chr3:146211800-146213600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr3:146211800-146213800	Weak transcription	NHDF-Ad	bronchial
43	chr3:146212000-146213800	Weak transcription	Muscle Satellite Cultured Cells	--
44	chr3:146212000-146214000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr3:146212800-146214800	Enhancers	K562	blood
46	chr3:146213000-146215600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr3:146213600-146215000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
48	chr3:146213600-146215000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
49	chr3:146213800-146214600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr3:146213800-146214600	Enhancers	Muscle Satellite Cultured Cells	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links